Andrew Hedin is a partner in Bessemer’s Cambridge office where he focuses on investments broadly across the healthcare ecosystem, including new biotech therapeutics as well as software and services sold to healthcare verticals.
Prior to joining Bessemer in 2015, Andrew worked at F-Prime Capital, Fidelity’s healthcare-focused venture capital fund where he invested in early-stage biotech and digital health technologies, as well as Leerink Partners as an advisor to the biopharma industry.
He earned an MBA with honors from The Wharton School, where he majored in health care management and finance, as well as a degree in biological basis of behavior from the University of Pennsylvania.
“The world needs tenacious healthcare founders now more than ever. Patients’ lives will be permanently better off because these teams are just crazy enough to be up for the task.”
Collective Medical empowers care teams to improve patient outcomes by closing the communication gaps that undermine patient care. Collective Medical was acquired by PointClickCare Technologies in December 2020.
CopilotIQ of at-home medical care for people with high blood pressure, diabetes, and heart disease which uses monitoring technology, personalized care, and one-on-one weekly nurse calls.
Peptone is an artificial intelligence and advanced atomic imaging techniques company that pursues a tricky class of potential targets for new medicines.
Qventus optimizes decisions in hospitals in real time to reduce costs, improve quality and experience.
Rimsys is the leading regulatory information management software for medtech.
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Subtle Medical uses AI to redefine the standards for medical imaging, making it faster, safer, and smarter.
Watershed is a verticalized Bio-IT cloud data lab technology that finds bioinformatics tools for biologists, helping biologists and bioinformaticians with assistance for more efficient and effective experimentation.
